Lack of prognostic value of insulin-like growth factor-1 in patients with breast cancer: Analysis with tissue microarray

Anticancer Research

Volumn 27, Issue 5 B, 2007, Pages 3541-3544

  Sheen Chen, Shyr Ming ^a   Chou, Fong Fu ^a   Hsu, Wayne ^a   Huang, Chao Cheng ^a   Eng, Hock Liew ^a   Tang, Rei Ping ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; IGF 1; Insulin like growth factor 1; Tissue microarray

Indexed keywords

ESTROGEN RECEPTOR; SOMATOMEDIN C;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 35348977192     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Holdaway IM, Mason BH and Lethaby VS: Serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer. ANZ J Surg 73: 905-908, 2003.
2. Khandwawala HM, McCurcheon IE, Flyvbjerg A and Friend KE: The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21: 215-244, 2000.
3. Jones JI and Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34, 1995.
4. Yu H and Rohan T: Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst (Bethesda) 92: 1472-1489, 2000.
5. Khandwala HM, McCutcheon IE, Flyvbjerg A and Friend KE: The effect of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21: 215-244, 2000.
6. Chan JM, Stampfer MJ and Giovannucci E: Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 279: 563-566, 1998.
7. Hankinson SE, Willett WC and Colditz GA: Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351: 1393-1396, 1998.
8. Ma J, Pollak MN and Giovannucci E: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Natl Cancer Inst 91: 620-625, 1999.
9. Yu H, Spitz MR and Mistry J: Plasma levels of insulin-like growth factor-1 and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91: 151-156, 1999.
10. Moch H, Kononen J, Kallioniemi OP and Sauter G: Tissue microarrays: what will they bring to molecular and anatomic pathology. Adv Anat Pathol 8: 14-20, 2001.
11. Rijn MVD and Gilks CB: Applications of microarrays to histopathology. Histopathology 44: 97-108, 2004.
12. The World Health Organization Histological Typing of Breast Tumor, 2nd ed. Am J Clin Pathol 78: 808-816, 1982.
13. Sheen-Chen S-M, Chen W-J, Eng H-L and Chou F-F: Serum concentration of tumor necrosis factor in patients with breast cancer. Breast Cancer Res Treat 43: 211-215, 1997.
14. Sheen-Chen S-M, Eng H-L, Chou F-F and Chen W-J: The prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer. Arch Surg 132: 264-267, 1997.
15. Sheen-Chen S-M, Chen W-J, Eng H-L and Chou F-F: Serum-soluble interleukin-2 receptor concentrations in patients with breast cancer: A preliminary report. Chang Gung Med J 21: 133-138, 1998.
16. Sheen-Chen S-M, Chou F-F, Eng H-L and Chen W-J: An evaluation of the prognostic significance of HLA-DR expression in axillary-node-negative breast cancer. Surgery 116: 510-515, 1994.
17. Sheen-Chen S-M, Eng H-L, Sheen C-W and Cheng Y-F: Serum levels of circulating intercellular adhesion molecule-1 in patients with breast cancer. Anticancer Res 17: 282-236, 1997.
18. Sheen-Chen S-M, Chen W-J and Eng H-L: Evaluation of the prognostic value of serum soluble CD44 in patients with breast cancer. Cancer Invest 17: 581-585, 1999.
19. Perrone EE, Theoharis C, Mucci NR and Hayasaka S: Tissue microarray assessment of prostate cancer tumor proliferation in African-American and white men. J Natl Cancer Inst 92: 937-939, 2000.
20. Kononen J, Bubendorf L and Kallioniemi A: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847, 1998.
21. Schraml P, Kononen J and Bubendorf L: Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 5: 1966-1975, 1999.
22. Torhorst J, Bucher C and Kononen J: Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159: 2249-2256, 2001.
23. Zhang D, Salto-Tellez M, Putti TC, Do E and Koay ES: Reliability of tissue microarray in detecting protein expression and gene amplification in breast cancer. Modern Pathol 16: 79-84, 2003.
24. Peyrat JP, Bonneterre J, Hecquet B and Vennin P: Plasm insulin-like growth factor-1(IGF-1) concentrations in human breast cancer. Eur J Cancer 29A: 492-497, 1993.
25. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, de Jong-Bakker M and Nooijen WJ: Insulin resistance and breast-cancer risk. Int J Cancer 52: 511-516, 1992.
26. Favoni RE, de Cupis A, Perrotta A, Sforzini S, Amoroso D, Pensa F and Miglietta L: Insulin-like growth factor-1(IGF-1) and IGF-binding proteins blood serum levels in women with early-and late-stage breast cancer: mutual relationship and possible correlations with patients' hormonal status. J Cancer Res & Clin Oncol 121: 674-682, 1995.
27. Sancak B, Coskun U, Gunel N, Onuk E, Cihan A, Karamercan A, Yildirim Y and Ozkan S: No aoociation between serum levels of insulin-like growth factor-1, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery. Inter Med J 34: 310-315, 2004.